Leishmaniasis Clinical Trials

Find Leishmaniasis Clinical Trials Near You

New And Recurrent Visceral Leishmaniasis in HIV Co-Infected Ethiopian Patients: a Cohort Study

Status: Recruiting
Location: See location...
Study Type: Observational
SUMMARY

The aim is (1) to better understand the underlying causes and predispositions for relapse and parasite persistence in visceral leishmaniasis (VL) patients living with HIV and (2) to improve treatment monitoring of this target group in Ethiopia

Eligibility
Participation Requirements
Sex: All
Minimum Age: 18
Healthy Volunteers: f
View:

• VL-HIV infection 1.1. VL: microscopically confirmed parasite presence in spleen or bone marrow tissue at first episode or relapse; for known active chronic cases: decision to treat VL 1.2. HIV: confirmed viral infection (new or past)

• ≥18 years

Locations
Other Locations
Ethiopia
University of Gondar
RECRUITING
Gonder
Contact Information
Primary
Nicole Berens-Riha
nberens@itg.be
0460850115
Backup
Johan van Griensven
jvangriensven@itg.be
Time Frame
Start Date: 2025-10-21
Estimated Completion Date: 2027-12
Participants
Target number of participants: 20
Related Therapeutic Areas
Sponsors
Collaborators: Armauer Hansen Research Institute, Ethiopia, University of Gondar
Leads: Institute of Tropical Medicine, Belgium

This content was sourced from clinicaltrials.gov